PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA
The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | ita |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies. |
|---|